Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Chronic Progressive

Explore clinical trials studying Multiple Sclerosis, Chronic Progressive. Study availability and eligibility vary by location and protocol.

186 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Chronic Progressive trial results

Completed

A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo

NCT02284568

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Teva Investigational Site 12966 Phoenix, Arizona, United States
  • Teva Investigational Site 12967 Newport Beach, California, United States
  • Teva Investigational Site 12962 San Francisco, California, United States
  • Teva Investigational Site 12964 Aurora, Colorado, United States
View all 99 locations
View Trial Details
Completed

A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients

NCT03560739

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Charcot-Marie-Tooth disease, Type 1F, +11 more
Locations
  • Novartis Investigative Site Fullerton, California, United States
  • Novartis Investigative Site Aurora, Colorado, United States
  • Novartis Investigative Site Basalt, Colorado, United States
  • Novartis Investigative Site Boulder, Colorado, United States
View all 41 locations
View Trial Details

Related conditions